REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

"Fresenius Kabi Polska" Sp. z o.o. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: "Fresenius Kabi Polska" Sp. z o.o. Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Fresenius Kabi Polska Sp. z o.o. is a subsidiary of Fresenius Kabi, a global healthcare company specializing in the production of clinical nutrition, life-saving drugs, and infusion and transfusion technologies.

Headquarters
Ul. Aleje Jerozolimskie 134
Warsaw; Mazowieckie; Postal Code: 02-305

Contact Details: Purchase the "Fresenius Kabi Polska" Sp. z o.o. report to view the information.

Website: http://www.fresenius-kabi.pl

Basic Information
Total Employees:
Purchase the "Fresenius Kabi Polska" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Fresenius Kabi Polska" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Fresenius Kabi Polska" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Fresenius Kabi Polska" Sp. z o.o. report to view the information.
Incorporation Date:
June 27, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Dom Medica Sp. z o.o.
99.99%
Company Performance
Financial values in the chart are available after "Fresenius Kabi Polska" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.99%▲
Total operating revenue
14.34%▲
Operating profit (EBIT)
21.6%▲
EBITDA
17.67%▲
Net Profit (Loss) for the Period
27.25%▲
Total assets
12.91%▲
Total equity
9%▲
Operating Profit Margin (ROS)
0.6%▲
Net Profit Margin
0.83%▲
Return on Equity (ROE)
1.95%▲
Quick Ratio
0.04%▲
Cash Ratio
0.01%▲

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Bayer Sp. z o.o.
"Roche Polska" Sp. z o.o.
 
Lek S.A.
Teva Operations Poland Sp. z o.o.
 
Adamed Pharma S.A.
Niopharma Labs Polska Sp. z o.o.
 
Pcs Europe Sp. z o.o.
Blau Farma Group Sp. z o.o. - S.K.A.
 
Nika Health Products Sp. z o.o.
Probiome Sp. z o.o.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo